Table 3. Intervention process measures among women identified as at high risk for preterm birth in intervention clusters.

	n/N (%)
Women identified as at high risk for preterm birth by the intervention	6214/48 219* (13%)
Location of identification
Community level	3741/6214 (60%)
Primary health care	1666/6214 (27%)
Hospital	807/6214 (13%)
Location of first dose administration
Community level	1209/6109 (20%)
Primary health care	3853/6109 (63%)
Hospital	1047/6109 (17%)
Maternal conditions at time of antenatal corticosteroid use
Signs of preterm labour	4789/6214 (77%)
Preterm premature rupture of membranes	1204/6214 (19%)
Haemorrhage	432/6214 (7%)
Hypertension	902/6214 (15%)
Other	186/6214 (3%)
Estimated gestational age at identification (weeks)
20–23	8/6026 (<1%)
24–27	778/6026 (13%)
28–32	2190/6026 (36%)
33–36	3031/6026 (50%)
37–39	19/6026 (<1%)
Received antenatal corticosteroids	6109/6214 (98%)
Antenatal corticosteroid kits with dexamethasone doses (6 mg) used
1 dose	1316/5973 (22%)
2 doses	317/5973 (5%)
3 doses	149/5973 (2%)
4 doses (complete course)	4191/5973 (70%)

The denominator for all percentages apart from the first is the number of women identified as at high risk for preterm birth by the intervention, excluding missing data (varies by characteristic).

^*48 219 is the total number of pregnant women enrolled in intervention clusters.